Baidu Inc (BIDU) 157.60 $BIDU After Yesterday's Rally of

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Baidu Inc (BIDU) 157.60 $BIDU

After Yesterday's Rally of 2.67% Shares Could Potentially Pullback
Comtex SmarTrend(R) - 1 hr 45 mins ago
Baidu (NASDAQ:BIDU) traded in a range yesterday that spanned from a low of $156.06 to a high of $159.87. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $154.98 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIDU: 157.60 (+4.10)

SmarTrend Watching for Potential Pullback in Shares of Baidu After 2.67% Gain
Comtex SmarTrend(R) - 1 hr 46 mins ago
Baidu (NASDAQ:BIDU) traded in a range yesterday that spanned from a low of $156.06 to a high of $159.87. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $154.98 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIDU: 157.60 (+4.10)

Stocks Rally Ahead of Next Week's Fed Meeting, Apple Earnings
at The Street - Fri Oct 23, 3:16PM CDT
The question now is whether the market's feel-good mood will carry over into the coming week, especially with the Federal Reverse's latest policy meeting mid-week.
XOM: 82.98 (+0.09), PYPL: 34.99 (+0.20), INTC: 34.90 (+0.50), YHOO: 33.17 (+1.50), P: 12.39 (-6.80), XLK: 43.83 (+1.19), ABBV: 50.34 (+2.07), GOOGL: 719.33 (+38.19), TMUS: 41.27 (+0.83), TWTR: 30.28 (+1.13), MSFT: 52.87 (+4.84), AAPL: 119.08 (+3.58), GPRO: 29.15 (+0.43), PSX: 83.35 (+0.74), AMZN: 599.03 (+35.12), EXC: 29.86 (-1.15), FB: 102.19 (+2.52), PFE: 34.05 (+0.72), STX: 41.15 (+1.91), VFC: 63.75 (-9.46), BIDU: 157.60 (+4.10), GILD: 107.99 (+0.39), PG: 77.03 (+2.18), CVX: 91.24 (-0.38), CMCSA: 61.98 (+0.28), BABA: 75.62 (+4.63)

Stocks Extend Highs as China Caps Off Week With Rate Cut
at The Street - Fri Oct 23, 1:52PM CDT
The People's Bank of China's effort to address its slowdown boosts U.S. stocks, while Amazon, Microsoft and Alphabet rally on earnings.
YHOO: 33.17 (+1.50), AMZN: 599.03 (+35.12), BIDU: 157.60 (+4.10), P: 12.39 (-6.80), FB: 102.19 (+2.52), VFC: 63.75 (-9.46), XLK: 43.83 (+1.19), PYPL: 34.99 (+0.20), GOOGL: 719.33 (+38.19), PG: 77.03 (+2.18), INTC: 34.90 (+0.50), MSFT: 52.87 (+4.84), AAPL: 119.08 (+3.58), BABA: 75.62 (+4.63)

Tech Stocks Lead Rally on Microsoft, Amazon Earnings
at The Street - Fri Oct 23, 10:20AM CDT
Stocks jump Friday after shares of tech trio Amazon, Alphabet and Microsoft rally on better-than-expected earnings.
AMZN: 599.03 (+35.12), FB: 102.19 (+2.52), VFC: 63.75 (-9.46), PYPL: 34.99 (+0.20), INTC: 34.90 (+0.50), T: 33.74 (-0.22), YHOO: 33.17 (+1.50), BIDU: 157.60 (+4.10), P: 12.39 (-6.80), XLK: 43.83 (+1.19), AAL: 45.67 (-0.32), GOOGL: 719.33 (+38.19), PG: 77.03 (+2.18), MSFT: 52.87 (+4.84), AAPL: 119.08 (+3.58), BABA: 75.62 (+4.63)

Alibaba Earnings Coming During Challenging Time
at Investor's Business Daily - Fri Oct 23, 7:02AM CDT
During what's been a tough year, Alibaba (BABA) will report quarterly earnings before the market open Tuesday, with expectations of continued double-digit growth. The China e-commerce giant is expected to report revenue of $3.35 billion at current...
AMZN: 599.03 (+35.12), BIDU: 157.60 (+4.10), JD: 27.10 (+0.90), BABA: 75.62 (+4.63)

5 High-Risk, High-Reward Stocks We're Watching
Brian Feroldi, Dan Caplinger, Matthew Frankel, Jordan Wathen, and Cheryl Swanson, The Motley Fool - Motley Fool - Fri Oct 23, 5:24AM CDT
Image source: Pictures of Money via Flickr Creative Commons. While we Fools tend to fill our portfolios with companies on rock-solid financial footing in dominate competitive positions, we certainly recognize that it can be prudent to invest in...
BLUE: 83.10 (+6.73), BIDU: 157.60 (+4.10), AFH: 18.56 (-0.17), CEMP: 18.00 (+2.24)

Comcast Boosts Baidu's iQiyi As China Video War Rages
at Investor's Business Daily - Thu Oct 22, 3:43PM CDT
Comcast's (CMCSA) Universal Pictures provided Baidu's (BIDU) online video platform iQiyi with more ammunition in its battle against Alibaba (BABA) and Tencent (TCEHY) for streaming supremacy in China. Expanding an existing agreement, Universal signed...
NFLX: 100.04 (+2.72), BIDU: 157.60 (+4.10), YOKU: 24.61 (-0.04), CMCSA: 61.98 (+0.28), BABA: 75.62 (+4.63)

What's in Store for Sohu.com (SOHU) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 1:25PM CDT
Sohu.com Inc. (SOHU) is set to report third-quarter 2015 results on Oct 26.
BIDU: 157.60 (+4.10), FISV: 95.75 (+1.24), AKAM: 74.08 (+1.55), SOHU: 45.35 (+0.35)

Amazon, eBay, Facebook, Yahoo! Driving Online Shopping Trends
at The Street - Thu Oct 22, 5:45AM CDT
Internet search engines are increasingly driving global online shopping trends, according to a new survey conducted by Pitney Bowes.
YHOO: 33.17 (+1.50), AMZN: 599.03 (+35.12), WB: 16.65 (+0.28), BIDU: 157.60 (+4.10), EBAY: 28.16 (+0.58), PBI: 21.22 (+0.24), FB: 102.19 (+2.52), TWTR: 30.28 (+1.13), MSFT: 52.87 (+4.84), GOOG: 702.00 (+50.21), YNDX: 13.22 (+0.36), BABA: 75.62 (+4.63)

Feeling Brave? It May Be Time to Look at Chinese Stocks Again
at The Street - Thu Oct 22, 5:11AM CDT
American investors eager to trade Chinese stocks after a dramatic mid-year fall can test them at home without restrictions but with buyer-beware caveats.
BIDU: 157.60 (+4.10), CEO: 117.02 (-0.20), JD: 27.10 (+0.90), PTR: 82.38 (+0.52), BABA: 75.62 (+4.63)

iQIYI's CEO Attends UK "Creativity Is Great" Forum
PR Newswire - Thu Oct 22, 3:00AM CDT
iQIYI, an independently operated subsidiary of Baidu (NASDAQ:BIDU) and one of the largest internet and mobile video service providers in China, today announced that iQIYI's founder and CEO Mr. Yu Gong attended the UK-China "Creativity is Great" forum during President Xi Jinping's state visit to the United Kingdom.
BIDU: 157.60 (+4.10)

Microsoft Corporation Enlists Allies To Battle Alphabet Inc In Russia and China
Leo Sun, The Motley Fool - Motley Fool - Tue Oct 20, 6:30PM CDT
In recent years, Microsoft 's biggest adversary has been Alphabet 's Google, which attacked the tech titan with free productivity software, operating systems, and a massive ecosystem of web...
QIHU: 54.14 (+0.45), BIDU: 157.60 (+4.10), GOOGL: 719.33 (+38.19), MSFT: 52.87 (+4.84), GOOG: 702.00 (+50.21), YNDX: 13.22 (+0.36)

Baidu (BIDU) Stock is the ‘Chart of the Day’
at The Street - Tue Oct 20, 10:44AM CDT
Baidu (BIDU) stock is Tuesday’s ‘Chart of the Day.’
BIDU: 157.60 (+4.10)

5 Stocks That Could Double In 2016
Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, and Cheryl Swanson, The Motley Fool - Motley Fool - Tue Oct 20, 5:26AM CDT
Photo by Sam valadi Flickr Creative Commons Most investors are constantly on the hunt for stocks that could double quickly, as stocks that go up 100% or more in a single year can go a long way towards helping you crush the market. Of course,...
INO: 6.61 (+0.22), BIDU: 157.60 (+4.10), MPEL: 18.39 (+1.28), PTCT: 25.60 (+0.61), KERX: 4.47 (-0.20)

Watch for Baidu to Potentially Pullback After Gaining 2.44% Yesterday
Comtex SmarTrend(R) - Mon Oct 19, 3:50PM CDT
Baidu (NASDAQ:BIDU) traded in a range yesterday that spanned from a low of $149.04 to a high of $155.86. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $152.38 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIDU: 157.60 (+4.10)

Alibaba Bid For Youku Threatens Netflix China Efforts
at Investor's Business Daily - Fri Oct 16, 1:30PM CDT
In a big expansion of its push into video streaming and Hollywood entertainment, Alibaba (BABA) made an offer to acquire the Chinese equivalent of YouTube, Youku Tudo (YOKU), in an all-cash deal valued at $3.6 billion. It's the latest of many...
NFLX: 100.04 (+2.72), BIDU: 157.60 (+4.10), DIS: 113.09 (-0.16), YOKU: 24.61 (-0.04), BABA: 75.62 (+4.63)

Why Baidu Inc Is a Screaming Buy
Sean O'Reilly, The Motley Fool - Motley Fool - Thu Oct 15, 1:07PM CDT
It seems that you can't give away shares in Chinese companies these days. The Hang Seng Index is off 21% from its highs of the early summer, and worries surrounding China's economy itself compound by the day. Amidst all of this, one of the...
BIDU: 157.60 (+4.10), GOOGL: 719.33 (+38.19), GOOG: 702.00 (+50.21)

iQIYI to Further Enhance Paid Subscription Offering
PR Newswire - Wed Oct 14, 9:00PM CDT
iQIYI, an independently operated subsidiary of Baidu (NASDAQ: BIDU) and one of the largest Internet and mobile video service providers in China, today announced that it will enhance its paid subscription offering in 2016 by purchasing and producing over 40 new shows. The investment is expected to account for approximately 50% of iQIYI's overall budget for the full year 2016. iQIYI also announced that three famous Chinese stars, Yang Yang, Angelababy and Huang Bo will become image ambassadors for the iQIYI subscription business.
BIDU: 157.60 (+4.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Activewear Faces Class Action over Alleged Fraud

Updated Category News Views 10

A Battle Over the Truth: Gildan's Legal Troubles Alright, buckle up, folks—it's time to dig deep into the gritty side of investing, where the glossy annual reports meet cold, hard skepticism. Gildan Activewear Inc., or GIL on the NYSE if you're still keeping track, has managed to embroil itself in some legal stews that even a seasoned trader like me can't ignore. Let's...

Continue Reading
Labcorp Scoops Up BioReference Health For $722M+

Updated Category News Views 7

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Continue Reading
HYPOTHESIS Blends Style and Function in Health Gear

Updated Category News Views 5

Pushing the Limits with HYPERX Knit Look, healthcare workers ain't just clocking in and out—they're on their feet all day, twisting, reaching, and moving. So when HYPOTHESIS tossed this shin-dig in Los Angeles for their HYPERX knit collection, it wasn't just to show off some snazzy scrubs. It was about bridging a gap: wellness meets grind. You reckon a pair of old...

Continue Reading
Brewer Foundation Shatters Records with IPPF Entries

Updated Category News Views 2

A New Milestone in Global Debate The Brewer Foundation is making waves across the debate world, claiming a groundbreaking enrollment for their 2026-27 International Public Policy Forum (IPPF). Let’s talk numbers for a moment—506 teams from a whopping 62 different countries, not to mention new entries from places like France, Mexico, Curaçao, and Russia, all eager to...

Continue Reading
EQT's Bold Move: Qiagen Takeover Offer

Updated Category News Views 4

Strategic Moves in Biotech: The EQT-Qiagen Deal EQT Private Equity's latest maneuver has seasoned investors raising an eyebrow. They've just put an all-cash public takeover offer on the table for Qiagen, and no, this isn't your run-of-the-mill acquisition—it's a play steeped in strategy and capital dynamics. EQT's Portfolio Puzzle: Where Does Qiagen Fit? Let's break it...

Continue Reading
Pearson Targets 2026 Growth with Strategic Moves

Updated Category News Views 2

Pearson's Q3 Performance: Crunch Time Checking the rearview mirror at Pearson's nine-month journey into 2026, it's quite the sight. Q3 revved up with a 6% growth spurt, aligning neatly with market expectations. Ain't that a relief in today's rocky terrain of education and assessment? Holding a tight rein, they're on course to meet the mid-single digit revenue growth they...

Continue Reading
Essity's Q3 2026: Profits Hold Firm Amid Challenges

Updated Category News Views 3

Essity's Balance Act in Q3: A Close Examination No looking through rose-tinted glasses here—Essity navigated the third quarter of 2026 with mixed indicators. Despite the broad strokes of stability, there's plenty beneath the surface worth a seasoned investor's eye. The company's net sales inched up by 4.1% to SEK 36,060 million. A nice figure, sure, but if you peek...

Continue Reading
Ben Felton to Lead AEIC as President for 2027

Updated Category News Views 3

A New Face at the Helm of AEIC If you’ve been keeping tabs on the utility sector, then the recent shuffling of chairs over at the Association of Edison Illuminating Companies (AEIC) might have caught your eye. They just wrapped up their 142nd Annual Meeting in Ojai, where Ben Felton from Portland General Electric stepped into the limelight as the incoming President for...

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 5

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
Annual Flu Shots May Save Lives: Accordia Health's Call

Updated Category News Views 3

Flu Season Isn't Just Sniffles: Accordia Health Speaks Up Listen up folks, it’s that time again and no, it ain’t just about digging out last year's scarf. Flu season is rolling in faster than a train outta hell, and already folks are talking about flu cases creeping up during the summer sunshine. We got Dr. Cameron Kilpatrick over at Accordia Health ringing the bell...

Continue Reading

Top 5 Most Recently Viewed Articles

Celmatix Unveils Innovative JNK Inhibitor for Women's Health

Updated Category News Views 354

Celmatix Therapeutics Announces New Drug Program Celmatix Therapeutics, a biotechnology company dedicated to women's health, has recently launched an ambitious drug program focusing on a novel Jun-N-terminal kinase (JNK) inhibitor. This innovative therapeutic drug candidate is designed to effectively target pain and inflammation associated with various female health...

Continue Reading
Accelera's 100 MW Electrolyzer Powers Green Hydrogen Vision

Updated Category News Views 226

Accelera's Role in Green Hydrogen Production Accelera by Cummins, recognized for its commitment to zero-emissions solutions, is set to revolutionize the green hydrogen landscape with a groundbreaking 100-megawatt (MW) proton exchange membrane (PEM) electrolyzer system. This development, aimed at enhancing renewable energy projects, will play an instrumental role in bp's...

Continue Reading
Curinos Amplero Achieves Gold Recognition at MarCom Awards

Updated Category News Views 182

Curinos Amplero's Award-Winning AI Solution Recently, Curinos, a leading data intelligence firm in the financial sector, achieved prestigious recognition at the MarCom Awards for its innovative AI-powered platform, Amplero Personalization Optimizer. This platform, celebrated for its generative AI capabilities, played a vital role in the Private Wealth Cross-Sell Campaign...

Continue Reading
Florida Housing Market Trends: Sales Surge in 2025

Updated Category News Views 273

Florida Housing Market Trends Overview As we dive into the current state of Florida's housing market, it's clear that exciting developments are taking place. In September, the sales of existing single-family homes experienced a robust increase of 13.6% compared to the previous year. Similarly, the sales of existing condo-townhouse units rose by 8% within the same...

Continue Reading
Oakio Achieves Excellence at Batimat 2024 Showcase

Updated Category News Views 181

Oakio Concludes Successful Participation at Batimat 2024 Oakio has successfully concluded its participation in Batimat 2024, a notable event held recently. This exhibition provided an excellent platform for showcasing a wide array of innovative Wood-Plastic Composite (WPC) solutions while connecting with industry professionals from around the world. Highlighting...

Continue Reading